Calcitonin-Salmon
Helps slow bone loss and may reduce bone pain, supporting skeletal health in postmenopausal women.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- calcitonin-salmon
- Brand Names
- Miacalcin, Fortical
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Musculoskeletal, Endocrine
- Prescribing Specialties
- Endocrinology, Primary care
What it does
Calcitonin-Salmon is an FDA-approved medication that your doctor can prescribe. Synthetic salmon calcitonin that inhibits osteoclast-mediated bone resorption and may have analgesic effects on bone pain.
How it's taken
Daily nasal spray
Subcutaneous or intramuscular injection
How people access it
Prescribed by a doctor for osteoporosis. The nasal spray form is most commonly used and filled at a regular pharmacy.
What doctors prescribe it for
- Postmenopausal osteoporosis in women who cannot or will not take other osteoporosis treatments
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Calcitonin-Salmon through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Miacalcin to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Calcitonin-Salmon (Miacalcin, Fortical) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Calcitonin-Salmon is FDA-approved for: Postmenopausal osteoporosis in women who cannot or will not take other osteoporosis treatments. Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Calcitonin-Salmon through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Calcitonin-Salmon compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides